Form 4 for ALLR Allarity Therapeutics, Inc.
Accepted 2025-01-24 00:00:00 ET · period of report 2025-01-22 · accession 0001437749-25-001808 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-24 | 2025-01-22 | ALLR | Graff Jeremy R. | CDO | A - Grant | $0.00 | +144.4K | 262.9K | +122% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-22 | A | A | 144,441 | $0.00 | 262,924 | D | — | — | (F1) The restricted stock units, or RSUs, granted on January 22, 2025 pursuant to Allarity Therapeutics, Inc's Amended and Restated 2021 Equity Incentive Plan, will vest in equal one-third installments on the first, second, and third anniversary of the grant, subject to the Reporting Person's continued relationship with the Issuer through each such date. |